171
Views
1
CrossRef citations to date
0
Altmetric
Review Article

Indications for transcatheter aortic valve implantation – now and next?

&
Pages 264-273 | Received 29 Oct 2014, Accepted 05 Mar 2015, Published online: 31 Mar 2015

References

  • Nkomo VT , Gardin JM , Skelton TN , Gottdiener JS , Scott CG , Enriquez-Sarano M . Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005–11.
  • Osnabrugge RL , Mylotte D , Head SJ , Van Mieghem NM , Nkomo VT , LeReun CM , et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol. 2013;62:1002–12.
  • Pellikka PA , Sarano ME , Nishimura RA , Malouf JF , Bailey KR , Scott CG , et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation. 2005;111:3290–5.
  • Ross J Jr , Braunwald E . Aortic stenosis. Circulation. 1968;38:61–7.
  • Mohr FW , Holzhey D , Mollmann H , Beckmann A , Veit C , Figulla HR , et al. The German Aortic Valve Registry: 1-year results from 13,680 patients with aortic valve disease. Eur J Cardiothorac Surg. 2014;46:808–16.
  • Hamm CW , Mollmann H , Holzhey D , Beckmann A , Veit C , Figulla HR , et al. The German Aortic Valve Registry (GARY): in-hospital outcome. Eur Heart J. 2014;35:1588–98.
  • Nowicki ER , Birkmeyer NJ , Weintraub RW , Leavitt BJ , Sanders JH , Dacey LJ , et al. Northern New England Cardiovascular Disease Study G, the Center for Evaluative Clinical Sciences DMS . Multivariable prediction of in-hospital mortality associated with aortic and mitral valve surgery in Northern New England. Ann Thorac Surg. 2004;77:1966–77.
  • Speziale G , Nasso G , Barattoni MC , Esposito G , Popoff G , Argano V , et al. Short-term and long-term results of cardiac surgery in elderly and very elderly patients. J Thorac Cardiovasc Surg. 2011;141:725–31.
  • Andersen HR , Knudsen LL , Hasenkam JM . Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J. 1992;13:704–8.
  • Cribier A , Eltchaninoff H , Bash A , Borenstein N , Tron C , Bauer F , et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106:3006–8.
  • Rodes-Cabau J , Dumont E , De LaRochelliere R , Doyle D , Lemieux J , Bergeron S , et al. Feasibility and initial results of percutaneous aortic valve implantation including selection of the transfemoral or transapical approach in patients with severe aortic stenosis. Am J Cardiol. 2008;102:1240–6.
  • Moat NE , Ludman P , de Belder MA , Bridgewater B , Cunningham AD , Young CP , et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol. 2011;58:2130–8.
  • Leon MB , Smith CR , Mack M , Miller DC , Moses JW , Svensson LG , et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607.
  • Smith CR , Leon MB , Mack MJ , Miller DC , Moses JW , Svensson LG , et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–98.
  • Adams DH , Popma JJ , Reardon MJ , Yakubov SJ , Coselli JS , Deeb GM , et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370:1790–8.
  • Paniagua D , Condado JA , Besso J , Velez M , Burger B , Bibbo S , et al. First human case of retrograde transcatheter implantation of an aortic valve prosthesis. Tex Heart Inst J. 2005;32:393–8.
  • Grube E , Schuler G , Buellesfeld L , Gerckens U , Linke A , Wenaweser P , et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol. 2007;50:69–76.
  • Kodali SK , Williams MR , Smith CR , Svensson LG , Webb JG , Makkar RR , et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366:1686–95.
  • Makkar RR , Fontana GP , Jilaihawi H , Kapadia S , Pichard AD , Douglas PS , et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med. 2012;366:1696–704.
  • Kapadia SR , Tuzcu EM , Makkar RR , Svensson LG , Agarwal S , Kodali S , et al. Long-Term Outcomes of Inoperable Patients with Aortic Stenosis Randomized to Transcatheter Aortic Valve Replacement or Standard Therapy. Circulation. 2014;130:1483–92.
  • Kapadia S . PARTNER I: Five-year results from a prospective, randomized trial of transcatheter aortic valve replacement with a balloon-expandable device versus conservative care in extremely high-risk patients with aortic stenosis. Transcatheter Cardiovascular Therapeutics, oral presentation. 2014.
  • Toggweiler S , Humphries KH , Lee M , Binder RK , Moss RR , Freeman M , et al. 5-year outcome after transcatheter aortic valve implantation. J Am Coll Cardiol. 2013;61:413–19.
  • Vahanian A , Alfieri O , Andreotti F , Antunes MJ , Baron-Esquivias G , Baumgartner H , et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33:2451–96.
  • Nishimura RA , Otto CM , Bonow RO , Carabello BA , Erwin JP 3rd , Guyton RA , et al. American College of Cardiology/American Heart Association Task Force on Practice G . 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63:2438–88.
  • Holmes DR Jr , Mack MJ , Kaul S , Agnihotri A , Alexander KP , Bailey SR , et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol. 2012;59:1200–54.
  • Roques F , Nashef SA , Michel P ; Euro Ssg . Risk factors for early mortality after valve surgery in Europe in the 1990s: lessons from the EuroSCORE pilot program. J Heart Valve Dis. 2001;10:572–8.
  • Ferguson TB Jr , Dziuban SW Jr , Edwards FH , Eiken MC , Shroyer AL , Pairolero PC , et al. The STS National Database: current changes and challenges for the new millennium. Committee to Establish a National Database in Cardiothoracic Surgery, The Society of Thoracic Surgeons. Ann Thorac Surg. 2000;69:680–91.
  • Wendt D , Thielmann M , Kahlert P , Kastner S , Price V , Al-Rashid F , et al. Comparison between different risk scoring algorithms on isolated conventional or transcatheter aortic valve replacement. Ann Thorac Surg. 2014;97:796–802.
  • Piazza N , Wenaweser P , van Gameren M , Pilgrim T , Tzikas A , Otten A , et al. Relationship between the logistic EuroSCORE and the Society of Thoracic Surgeons Predicted Risk of Mortality score in patients implanted with the CoreValve ReValving system–a Bern-Rotterdam Study. Am Heart J. 2010;159:323–9.
  • Hong SJ , Hong MK , Ko YG , Choi D , Hong GR , Shim JK , et al. Multidisciplinary team approach for identifying potential candidate for transcatheter aortic valve implantation. Yonsei Med J. 2014;55:1246–52.
  • Lancellotti P , Magne J , Donal E , Davin L , O’Connor K , Rosca M , et al. Clinical outcome in asymptomatic severe aortic stenosis: insights from the new proposed aortic stenosis grading classification. J Am Coll Cardiol. 2012;59:235–43.
  • Tribouilloy C , Rusinaru D , Marechaux S , Castel AL , Debry N , Maizel J , et al. Low-gradient, low-flow severe aortic stenosis with preserved left ventricular ejection fraction: characteristics, outcome, and implications for surgery. J Am Coll Cardiol. 2015;65:55–66.
  • Hansson NC , Thuesen L , Hjortdal VE , Leipsic J , Andersen HR , Poulsen SH , et al. Three-dimensional multidetector computed tomography versus conventional 2-dimensional transesophageal echocardiography for annular sizing in transcatheter aortic valve replacement: Influence on postprocedural paravalvular aortic regurgitation. Catheter Cardiovasc Interv. 2013;82:977–86.
  • Ussia GP , Barbanti M , Colombo A , Tarantini G , Petronio AS , Ettori F , et al. CoreValve Italian Registry I . Impact of coronary artery disease in elderly patients undergoing transcatheter aortic valve implantation: insight from the Italian CoreValve Registry. Int J Cardiol. 2013;167:943–50.
  • Gasparetto V , Fraccaro C , Tarantini G , Buja P , D’Onofrio A , Yzeiraj E , et al. Safety and effectiveness of a selective strategy for coronary artery revascularization before transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2013;81:376–83.
  • Wendt D , Kahlert P , Lenze T , Neuhauser M , Price V , Konorza T , et al. Management of high-risk patients with aortic stenosis and coronary artery disease. Ann Thorac Surg. 2013;95:599–605.
  • Griese DP , Reents W , Toth A , Kerber S , Diegeler A , Babin-Ebell J . Concomitant coronary intervention is associated with poorer early and late clinical outcomes in selected elderly patients receiving transcatheter aortic valve implantation. Eur J Cardiothorac Surg. 2014;46:e1–7.
  • Khawaja MZ , Wang D , Pocock S , Redwood SR , Thomas MR . The percutaneous coronary intervention prior to transcatheter aortic valve implantation (ACTIVATION) trial: study protocol for a randomized controlled trial. Trials. 2014;15:300.
  • Conrotto F , D’Ascenzo F , Francesca G , Colaci C , Sacciatella P , Biondi-Zoccai G , et al. Impact of Access on TAVI Procedural and Midterm Follow-Up: A Meta-Analysis of 13 Studies and 10,468 Patients. J Interv Cardiol. 2014;27:500–8.
  • Kempfert J , Van Linden A , Holzhey D , Rastan A , Blumenstein J , Mohr FW , et al. The evolution of transapical aortic valve implantation and new perspectives. Minim Invasive Ther Allied Technol. 2011;20:107–16.
  • Bramlage P , Romano M , Bonaros N , Cocchieri R , Jagielak D , Frank D , et al. Transaortic transcatheter aortic valve implantation rationale and design of the multicenter, multinational prospective ROUTE registry. BMC Cardiovasc Disord. 2014;14:152.
  • Martinez-Clark PO , Singh V , Cadena JA , Cucalon Reyes AM , Gallegos C , Dager A , et al. Transcaval retrograde transcatheter aortic valve replacement for patients with no other access: first-in-man experience with CoreValve. JACC Cardiovasc Interv. 2014;7:1075–7.
  • Muensterer A , Mazzitelli D , Ruge H , Wagner A , Hettich I , Piazza N , et al. Safety and efficacy of the subclavian access route for TAVI in cases of missing transfemoral access. Clin Res Cardiol. 2013;102:627–36.
  • De Robertis F , Asgar A , Davies S , Delahunty N , Kelleher A , Trimlett R , et al. The left axillary artery–a new approach for transcatheter aortic valve implantation. Eur J Cardiothorac Surg. 2009;36:807–12.
  • Modine T , Sudre A , Amr G , Delhaye C , Koussa M . Implantation of a Sapien XT aortic bioprosthesis through the left carotid artery. J Card Surg. 2014;29:337–9.
  • Thomas M , Schymik G , Walther T , Himbert D , Lefevre T , Treede H , et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2010;122:62–9.
  • Webb J , Gerosa G , Lefevre T , Leipsic J , Spence M , Thomas M , et al. Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve. J Am Coll Cardiol. 2014;64:2235–43.
  • Roberts WC , Vowels TJ , Ko JM . Natural history of adults with congenitally malformed aortic valves (unicuspid or bicuspid). Medicine (Baltimore). 2012;91:287–308.
  • Bauer T , Linke A , Sievert H , Kahlert P , Hambrecht R , Nickenig G , et al. Comparison of the effectiveness of transcatheter aortic valve implantation in patients with stenotic bicuspid versus tricuspid aortic valves (from the German TAVI Registry). Am J Cardiol. 2014;113:518–21.
  • Wijesinghe N , Ye J , Rodes-Cabau J , Cheung A , Velianou JL , Natarajan MK , et al. Transcatheter aortic valve implantation in patients with bicuspid aortic valve stenosis. JACC Cardiovasc Interv. 2010;3:1122–5.
  • Mylotte D , Lefevre T , Sondergaard L , Watanabe Y , Modine T , Dvir D , et al. Transcatheter aortic valve replacement in bicuspid aortic valve disease. J Am Coll Cardiol. 2014;64:2330–9.
  • Hayashida K , Bouvier E , Lefevre T , Chevalier B , Hovasse T , Romano M , et al. Transcatheter aortic valve implantation for patients with severe bicuspid aortic valve stenosis. Circ Cardiovasc Interv. 2013;6:284–91.
  • Himbert D , Pontnau F , Messika-Zeitoun D , Descoutures F , Detaint D , Cueff C , et al. Feasibility and outcomes of transcatheter aortic valve implantation in high-risk patients with stenotic bicuspid aortic valves. Am J Cardiol. 2012;110:877–83.
  • Christiansen S , Schmid M , Autschbach R . Perioperative risk of redo aortic valve replacement. Ann Thorac Cardiovasc Surg. 2009;15:105–10.
  • Vogt PR , Brunner-LaRocca H , Sidler P , Zund G , Truniger K , Lachat M , et al. Reoperative surgery for degenerated aortic bioprostheses: predictors for emergency surgery and reoperative mortality. Eur J Cardiothorac Surg. 2000;17:134–9.
  • Bapat V . Valve-in-valve apps: why and how they were developed and how to use them. EuroIntervention. 2014;10:U44–51.
  • Eggebrecht H , Schafer U , Treede H , Boekstegers P , Babin-Ebell J , Ferrari M , et al. Valve-in-valve transcatheter aortic valve implantation for degenerated bioprosthetic heart valves. JACC Cardiovasc Interv. 2011;4:1218–27.
  • Dvir D , Webb J , Brecker S , Bleiziffer S , Hildick-Smith D , Colombo A , et al. Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry. Circulation. 2012;126:2335–44.
  • Hildebrandt HA , Erbel R , Kahlert P . Compassionate use of the self-expandable medtronic CoreValve prosthesis for the treatment of pure aortic regurgitation in a patient at prohibitive risk for surgical valve replacement. Catheter Cardiovasc Interv. 2013;82:E939–43.
  • D’Ancona G , Pasic M , Buz S , Drews T , Dreysse S , Hetzer R , et al. TAVI for pure aortic valve insufficiency in a patient with a left ventricular assist device. Ann Thorac Surg. 2012;93:e89–91.
  • Roy DA , Schaefer U , Guetta V , Hildick-Smith D , Mollmann H , Dumonteil N , et al. Transcatheter aortic valve implantation for pure severe native aortic valve regurgitation. J Am Coll Cardiol. 2013;61:1577–84.
  • Wendt D , Kahlert P , Pasa S , El-Chilali K , Al-Rashid F , Tsagakis K , et al. Transapical transcatheter aortic valve for severe aortic regurgitation: expanding the limits. JACC Cardiovasc Interv. 2014;7:1159–67.
  • Barbanti M , Ye J , Pasupati S , El-Gamel A , Webb JG . The Helio transcatheter aortic dock for patients with aortic regurgitation. EuroIntervention. 2013;9(Suppl):S91–4.
  • Seiffert M , Bader R , Kappert U , Rastan A , Krapf S , Bleiziffer S , et al. Initial German Experience With Transapical Implantation of a Second-Generation Transcatheter Heart Valve for the Treatment of Aortic Regurgitation. JACC Cardiovasc Interv. 2014;7:1168–74.
  • Cheung A , Webb JG , Barbanti M , Freeman M , Binder RK , Thompson C , et al. 5-year experience with transcatheter transapical mitral valve-in-valve implantation for bioprosthetic valve dysfunction. J Am Coll Cardiol. 2013;61:1759–66.
  • Petronio A , Giannini C , De Carlo M , Guarracino F . Antegrade percutaneous valve implantation for mitral ring dysfunction, a challenging case. Catheter Cardiovasc Interv. 2012;80:700–3.
  • Hasan R , Mahadevan VS , Schneider H , Clarke B . First in human transapical implantation of an inverted transcatheter aortic valve prosthesis to treat native mitral valve stenosis. Circulation. 2013;128:e74–6.
  • Vahanian A , Himbert D , Iung B . Unmet clinical needs in transcatheter mitral valve interventions in 2014. EuroIntervention. 2014;10:U101–5.
  • Taramasso M , Maisano F . Transcatheter mitral valve repair - transcatheter mitral valve annuloplasty. EuroIntervention. 2014;10:U129–35.
  • Kahlert P , Knipp SC , Schlamann M , Thielmann M , Al-Rashid F , Weber M , et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation. 2010;121:870–8.
  • Linke A . Cerebral protection device reduces brain injury risk in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Transcatheter Cardiovascular Therapeutics, oral presentation 2014.
  • Vergnat M , Finet G , Rioufol G , Obadia JF . Percutaneous femoral artery access with Prostar device for innovative mitral and aortic interventions. Eur J Cardiothorac Surg. 2011;39:600–2.
  • Blumenstein J , Kempfert J , Van Linden A , Arsalan M , Schmidt SK , Mollmann H , et al. First-in-man evaluation of the transapical APICA ASC access and closure device: the initial 10 patients. Eur J Cardiothorac Surg. 2013;44:1057–62.
  • The United Kingdom Transcatheter Aortic Valve Implantation (UK TAVI) Trial . A multi-centre randomised controlled trial to assess the clinical effectiveness and cost utility of TAVI, compared with conventional surgical aortic valve replacement (AVR), in patients with severe symptomatic aortic stenosis at intermediate or high operative risk. http://www.uktavi.org.2014.
  • The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves . http://www.clinicaltrials.gov.2014.
  • Safety and Efficacy Study of the Medtronic CoreValvew System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI) . http://www.clinicaltrials.gov.2014.
  • Fairbairn TA , Meads DM , Hulme C , Mather AN , Plein S , Blackman DJ , et al. The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk. Heart. 2013;99:914–20.
  • Abdel-Wahab M , Mehilli J , Frerker C , Neumann FJ , Kurz T , Tolg R , et al. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA. 2014;311:1503–14.
  • Ielasi A , Latib A , Tespili M . Current and new-generation transcatheter aortic valve devices: an update on emerging technologies. Expert Rev Cardiovasc Ther. 2013;11:1393–405.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.